These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3588904)

  • 1. Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy.
    Adolph JM; Kimmig BN; Georgi P; zum Winkel K
    Radiology; 1987 Jul; 164(1):199-203. PubMed ID: 3588904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
    Dresel S; Tatsch K; Zachoval R; Hahn K
    Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid tumors: iodine-131 MIBG scintigraphy.
    Hanson MW; Feldman JM; Blinder RA; Moore JO; Coleman RE
    Radiology; 1989 Sep; 172(3):699-703. PubMed ID: 2772175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG.
    Hirano T; Otake H; Watanabe N; Oriuchi N; Zennyouji A; Fukuda T; Endo K
    J Nucl Med; 1995 Dec; 36(12):2243-5. PubMed ID: 8523113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical relevance of I-123/I-131-MIBG scintigraphy in intestinal carcinoid tumors].
    van de Flierdt E; Frank T; Laubenbacher C; Fink U; Bauer R; Langhammer HR; Pabst HW
    Nuklearmedizin; 1998 Jun; 37(4):129-33. PubMed ID: 9650212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
    Feldman JM; Blinder RA; Lucas KJ; Coleman RE
    J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
    Siproudhis L; Lescouarc'h J; Bretagne JF; Bourguet P; Raoul JL; Etienne PL; Herry JY; Gosselin M
    Gastroenterol Clin Biol; 1991; 15(11):789-93. PubMed ID: 1769467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine.
    Bomanji J; Levison DA; Zuzarte J; Britton KE
    J Nucl Med; 1987 Dec; 28(12):1907-10. PubMed ID: 3681447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
    Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.
    Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M
    Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of neuroectodermal tumors].
    Adolph J; Kimmig B
    Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.
    Hoefnagel CA; Den Hartog Jager FC; Van Gennip AH; Marcuse HR; Taal BG
    Clin Nucl Med; 1986 Mar; 11(3):150-2. PubMed ID: 3956021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
    Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE
    Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
    Fujishita T; Kishida M; Taki H; Shinoda C; Miyabayashi K; Fujishita M; Maruyama M; Mizushima Y; Kobayashi M
    Respirology; 2007 Nov; 12(6):928-30. PubMed ID: 17986127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I MIBG/111In octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin.
    Orsolon P; Bagni B
    Minerva Endocrinol; 1995 Jun; 20(2):145-7. PubMed ID: 8531897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.